Latanoprost Completed Phase 4 Trials for Glaucoma / Ocular Hypertension

IndicationsStatusPurposePhase
CompletedNot Available4
clinicaltrials.gov IdentifierTitleDrugs
NCT00950690Efficacy and Tolerability of Xalatan in Patients
NCT00348400Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost
NCT00347841Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost